| ivabradine / Generic mfg. |
ACTRN12618001675213: A Pilot, Randomised Controlled Study of Ivabradine for Heart Rate Reduction in Critically Ill Patients with Septic Shock |
|
|
| Not yet recruiting | 3 | 20 | | | Perioperative and Critical Care Research Monash Medical Centre , Monash health pharamcy department | Tachycardia, Critical illness, Septic shock | | | | |
2008-001201-42: Clinical trial on the use of ivabradine in patients with inappropriate sinus tachycardia |
|
|
| Ongoing | 3 | 10 | Europe | Ivabradine, | POLICLINICO SAN DONATO IRCSS | Inappropriate sinus tachycardia | | | | |
2016-002015-17: Usefulness of Ivabradine in the diagnosis of valvular heart disaease. |
|
|
| Ongoing | 3 | 25 | Europe | Ivabradine, s16257, Film-coated tablet | Odense University Hospital, Odense University Hospital | Aortic valve stenosis with reduced ejection fraction, Valvular heart disease with heart failure, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2018-000191-15: Effectiveness and Safety on Cardiac Frecuency Control With Ivabradine on the Cardiogenic Shock. Eficacia y seguridad del control de frecuencia cardÃaca mediante Ivabradina en el shock cardiogénico (ES-FISH) |
|
|
| Ongoing | 3 | 22 | Europe | Ivabradine, Film-coated tablet, Ivabradine. CAS number: 155974-00-8 | IRICYS- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal, IRICYS- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal | Cardiogenic Shock Shock cardiogénico, Heart failure Shock cardiogénico, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2015-002060-17: Effect of heart rate reduction on the arterial wall - Impact of aging Effet de la réduction de la fréquence cardiaque sur la paroi artérielle – impact du vieillissement |
|
|
| Not yet recruiting | 3 | 30 | Europe | Capsule, PROCORALAN | CHU - Hôpitaux de Rouen, CHU - Hôpitaux de Rouen | Healthy subjects between 25 and 65 years old Volontaires sains, d’âge compris entre 25 et 65 ans, Healthy subjects between 25 and 65 years old Volontaires sains, d’âge compris entre 25 et 65 ans, Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09] | | | | |
2020-004877-38: Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial |
|
|
| Not yet recruiting | 3 | 2500 | Europe | Capsule, Ivabradine Anpharm | Uniwersytet Jagielloński - Collegium Medicum, Agencja Badań Medycznych | Myocardial Injury after Noncardiac Surgery, Myocardial Injury after Noncardiac Surgery, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
| Recruiting | 3 | 200 | RoW | Ivabradine 7.5Mg Tab, Ivabradine, DOBUTamine Injectable Solution, Dobutamine | The Young Investigator Group of Cardiovascular Research | Heart Failure, Cardiogenic Shock, Ischemic Heart Disease | 01/23 | 01/23 | | |
| Recruiting | 3 | 429 | Europe | Ivabradine, Ivabradine Low, Ivabradine High, Placebo | Assistance Publique - Hôpitaux de Paris | Septic Shock | 09/24 | 12/24 | | |
| Recruiting | 3 | 2500 | Europe | Ivabradine, Placebo | Jagiellonian University, Population Health Research Institute, Vanderbilt University Medical Center | Myocardial Injury After Noncardiac Surgery (MINS), Myocardial Ischemia | 03/25 | 03/26 | | |
ACTRN12621000196842: Effect of Ivabradine use on exercise capacity in patients with transposition of the great arteries (TGA) post atrial switch repair |
|
|
| Recruiting | 2/3 | 20 | | | Melbourne Health, Royal Melbourne Hospital | Transposition of great arteries, Congenital heart disease | | | | |
